St. James Investment Company, LLC Viatris Inc Transaction History

St. James Investment Company, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$9.81 - $15.4 $10.5 Million - $16.5 Million	-1,069,544 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$12.09 - $14.68 $797,093 - $967,852	-65,930 Reduced 5.81%	1,069,544 $14.5 Million
Q3 2021 Nov 12, 2021	BUY	$13.25 - $15.13 $6.37 Million - $7.28 Million	481,102 Added 73.52%	1,135,474 $15.4 Million
Q2 2021 Aug 02, 2021	BUY	$12.97 - $16.15 $7.25 Million - $9.03 Million	558,880 Added 585.26%	654,372 $9.35 Million
Q1 2021 May 11, 2021	SELL	$13.59 - $18.54 $103,311 - $140,941	-7,602 Reduced 7.37%	95,492 $1.33 Million
Q4 2020 Feb 10, 2021	BUY	$14.3 - $18.74 $1.47 Million - $1.93 Million	103,094 New	103,094 $1.93 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of St. James Investment Company, LLC, based on Form 13F filings with the SEC.

Stay updated on St. James Investment Company, LLC with notifications on news.